Clinical Trial Detail

NCT ID NCT03656718
Title A Study of Subcutaneous Nivolumab Monotherapy With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications

colorectal cancer

melanoma

lung non-small cell carcinoma

renal cell carcinoma

hepatocellular carcinoma

Therapies

Nivolumab + rHuPH20

Age Groups: adult senior

No variant requirements are available.